Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Pelfrene, Alain F.
1991.
Classes of Pesticides.
p.
1271.
Mason, J. D. T.
Jardine, A.
and
Gibbin, K. P.
1992.
Foetal Warfarin Syndrome—a complex airway problem.
The Journal of Laryngology & Otology,
Vol. 106,
Issue. 12,
p.
1098.
Wong, V.
Cheng, C. H.
and
Chan, K. C.
1993.
Fetal and neonatal outcome of exposure to anticoagulants during pregnancy.
American Journal of Medical Genetics,
Vol. 45,
Issue. 1,
p.
17.
Shiozaki, Arihiro
Arai, Takashi
Izumi, Rikuichi
Niiya, Kenji
and
Sakuragawa, Nobuo
1993.
Congenital antithrombin III deficient neonate treated with antithrombin III concentrates.
Thrombosis Research,
Vol. 70,
Issue. 3,
p.
211.
Perloff, Joseph K.
1994.
Congenital heart disease and pregnancy.
Clinical Cardiology,
Vol. 17,
Issue. 11,
p.
579.
Pauli, R. M.
1997.
Drug Toxicity in Embryonic Development II.
Vol. 124 / 2,
Issue. ,
p.
191.
Kulman, John D.
Harris, Jeff E.
Xie, Ling
and
Davie, Earl W.
2001.
Identification of two novel transmembrane γ-carboxyglutamic acid proteins expressed broadly in fetal and adult tissues.
Proceedings of the National Academy of Sciences,
Vol. 98,
Issue. 4,
p.
1370.
Pelfrene, Alain F.
2001.
Handbook of Pesticide Toxicology.
p.
1793.
Eldor, Amiram
2001.
Unexplored territories in the nonsurgical patient: A look at pregnancy.
Seminars in Hematology,
Vol. 38,
Issue. ,
p.
39.
Van Driel, Dieneke
Wesseling, Judit
Sauer, Pieter J.J.
Touwen, Bert C.L.
Van Der Veer, Eveline
and
Heymans, Hugo S.A.
2002.
Teratogen update: Fetal effects after in utero exposure to coumarins Overview of cases, follow‐up findings, and pathogenesis.
Teratology,
Vol. 66,
Issue. 3,
p.
127.
Hunter, John G.
2002.
Craniomaxillofacial Reconstructive and Corrective Bone Surgery.
p.
49.
Eldor, Amiram
2002.
The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancy.
European Journal of Obstetrics & Gynecology and Reproductive Biology,
Vol. 104,
Issue. 1,
p.
3.
Walker, Isobel D
2003.
Arterial thromboembolism in pregnancy.
Best Practice & Research Clinical Haematology,
Vol. 16,
Issue. 2,
p.
297.
Meschia, James F.
2004.
Transient Ischemic Attacks.
p.
264.
Ageno, Walter
Crotti, Stefania
and
Turpie, Alexander GG
2004.
The safety of antithrombotic therapy during pregnancy.
Expert Opinion on Drug Safety,
Vol. 3,
Issue. 2,
p.
113.
Finkelstein, Yaron
Chitayat, David
Schechter, Tal
Keating, Sarah
Toi, Ants
and
Koren, Gideon
2005.
Warfarin Embryopathy Following Low-Dose Maternal Exposure.
Journal of Obstetrics and Gynaecology Canada,
Vol. 27,
Issue. 7,
p.
702.
2006.
Human Developmental Toxicants.
p.
193.
Buhimschi, Catalin S.
and
Weiner, Carl P.
2007.
Management of High‐Risk Pregnancy.
p.
38.
Duhl, Adam J.
Paidas, Michael J.
Ural, Serdar H.
Branch, Ware
Casele, Holly
Cox-Gill, Joan
Hamersley, Sheri Lynn
Hyers, Thomas M.
Katz, Vern
Kuhlmann, Randall
Nutescu, Edith A.
Thorp, James A.
and
Zehnder, James L.
2007.
Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes.
American Journal of Obstetrics and Gynecology,
Vol. 197,
Issue. 5,
p.
457.e1.
Khan, Arif O.
2007.
Optic Nerve Dysfunction in a Child Following Low-Dose Maternal Warfarin Exposure.
Ophthalmic Genetics,
Vol. 28,
Issue. 3,
p.
183.